Spyre Therapeutics Inc. (SYRE)
Spyre Therapeutics Max Pain By Strike
SYRE trades at $16.92, 3.3% below the near-term max pain of $17.5 expiring Sep 19, 2025 (31 days). Price stability likely with balanced options positioning at this level. Max pain is falling across expirations ($2.5-$60), signaling increased put positioning or downside protection. Key magnetic zone at 15 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Spyre Therapeutics Max Pain By Expiry
Max pain for SYRE shows a downward trend from 60 to 2.5, indicating bearish sentiment or hedging activity. The 271% spread signals divergent expectations across timeframes. Levels distributed around 16.92. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 17.5 | 0.58 (3.43%) |
| Oct 17, 2025 | 2.5 | -14.42 (-85.22%) |
| Dec 19, 2025 | 15 | -1.92 (-11.35%) |
| Jan 16, 2026 | 60 | 43.08 (254.61%) |
| Mar 20, 2026 | 17.5 | 0.58 (3.43%) |
| Jan 15, 2027 | 15 | -1.92 (-11.35%) |